Skip to content
TrialScanner

NCT04614636

FT538 in Subjects With Advanced Hematologic Malignancies

Phase 1TerminatedFATELead

Registry record

Lead sponsor
Fate Therapeutics
Conditions
Acute Myeloid Leukemia; AML, Adult; Multiple Myeloma; Myeloma
Primary completion
Jul 13, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04614636 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04614636: FT538 in Subjects With... | TrialScanner